不同产地艾绒艾灸治疗中重度原发性膝骨关节炎:三臂随机双盲假对照试验方案
本研究为三臂随机双盲假对照试验方案,计划纳入350例中重度原发性膝骨关节炎患者,按2:2:1随机分为湖北蕲春艾绒组、河南南阳艾绒组和假艾灸对照组。主要结局为第2周WOMAC疼痛评分较基线的变化,旨在验证艾灸疗效及艾绒产地是否影响疗效。
要点
- 试验采用三臂随机双盲假对照设计,纳入350例中重度原发性膝骨关节炎患者。
- 主要结局为第2周WOMAC疼痛评分较基线变化,第6周随访评估次要结局。
- 旨在验证艾灸疗效及艾绒产地(蕲春 vs 南阳)对疗效的贡献。
核心结论
- 该试验将有助于明确艾灸对膝骨关节炎的疗效,并判断艾绒产地是否影响艾灸效果。
研究设计与样本
- 三臂随机双盲假对照试验,计划纳入350例中重度原发性膝骨关节炎患者。
- 按2:2:1比例随机分配至A组(湖北蕲春艾绒)、B组(河南南阳艾绒)或C组(假艾灸对照)。
关键数值与推荐
- 主要结局:第2周WOMAC疼痛评分较基线的变化。
- 次要结局包括第6周WOMAC疼痛评分变化、膝关节疼痛视觉模拟评分、WOMAC总分、僵硬度评分、功能评分、患者总体评估及应答标准。
- 治疗为每次20分钟、每周3次、持续2周,随访4周。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: According to the traditional Chinese medicine theory, moxa floss is the best material for moxibustion; the effect of moxibustion is closely related to the habitats of moxa floss, among which Qichun County, Hubei Province, China, is considered as the genuine origin. However, this view has not been validated by clinical studies. Moxibustion has been proven effective in alleviating pain and improving physical function and quality of life for patients with knee osteoarthritis (KOA). This trial aims to determine whether the habitat of moxa floss contributes to the effect of moxibustion and to validate the effectiveness of moxibustion for KOA. METHODS: This is a three-armed, randomized, double-blinded, sham-controlled trial. A total of 350 patients with moderate to severe primary KOA will be randomly allocated to groups A, B, or C with a 2:2:1 ratio. Moxa stick moxibustion using moxa floss from different habitats will be applied in two experimental groups: group A, moxa floss from the habitat of Qichun County, Hubei Province, China; and group B, moxa floss from the habitat of Nanyang County, Henan Province. Group C will use non-moxa floss for sham moxibustion as control. Patients will be treated for 20 min per session, for three sessions per week for 2 weeks, and followed up for 4 weeks. The primary outcome will be the change from baseline in the pain score of the Western Ontario and McMaster Osteoarthritis Index (WOMAC) at week 2. Secondary outcomes will include a change in the WOMAC pain score at week 6; the visual analogue scale for knee pain, the total WOMAC score, the WOMAC stiffness score, the WOMAC function score, the patient global assessment, and the responder criteria at weeks 2 and 6. Adverse events will be assessed throughout the study. DISCUSSION: This trial will help to identify the effectiveness of moxibustion for KOA and whether the habitat of moxa floss contributes to the effect of moxibustion. TRIAL REGISTRATION: Acupuncture-Moxibustion Clinical Trial Registry: AMCTR-IOR-16000007 . Registered on 29 February 2016.
引用
- Xu H, Zhao H, Kang L, et al. Moxibustion using different habitat moxa floss for moderate to severe primary knee osteoarthritis: study protocol for a three-armed randomized, double-blinded, sham-controlled trial. Trials. 2018. PMID: 30053899. doi:10.1186/s13063-018-2794-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。